149 related articles for article (PubMed ID: 20214430)
1. Imaging techniques in pancreatic tumors.
D'Onofrio M; Gallotti A; Pozzi Mucelli R
Expert Rev Med Devices; 2010 Mar; 7(2):257-73. PubMed ID: 20214430
[TBL] [Abstract][Full Text] [Related]
2. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
3. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic cancer: current concepts in imaging for diagnosis and staging.
Tamm E; Charnsangavej C
Cancer J; 2001; 7(4):298-311. PubMed ID: 11561606
[TBL] [Abstract][Full Text] [Related]
5. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
6. [Non invasive methods in competition for EUS (US, CE-US, CT, MRI and PET/CT): the radiologist point of view].
Martina MC; Cassinis MC; Tappero C; Gandini G
Minerva Med; 2007 Aug; 98(4):343-50. PubMed ID: 17921948
[TBL] [Abstract][Full Text] [Related]
7. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI.
Cantwell CP; Setty BN; Holalkere N; Sahani DV; Fischman AJ; Blake MA
J Comput Assist Tomogr; 2008; 32(5):738-44. PubMed ID: 18830103
[TBL] [Abstract][Full Text] [Related]
8. The value of contrast-enhanced ultrasound in the characterization of vascular pattern of solid pancreatic lesions.
Ardelean M; Sirli R; Sporea I; Bota S; Danila M; Popescu A; Timar B; Buzas R; Mazilu O; Ardelean O; Lighezan D
Med Ultrason; 2015 Mar; 17(1):16-21. PubMed ID: 25745652
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic evaluation and palliation of pancreatic adenocarcinoma: current and future options.
Pausawasdi N; Scheiman J
Curr Opin Gastroenterol; 2007 Sep; 23(5):515-21. PubMed ID: 17762557
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer.
Strobel K; Heinrich S; Bhure U; Soyka J; Veit-Haibach P; Pestalozzi BC; Clavien PA; Hany TF
J Nucl Med; 2008 Sep; 49(9):1408-13. PubMed ID: 18703604
[TBL] [Abstract][Full Text] [Related]
11. Staging pathways in recurrent colorectal carcinoma: is contrast-enhanced 18F-FDG PET/CT the diagnostic tool of choice?
Soyka JD; Veit-Haibach P; Strobel K; Breitenstein S; Tschopp A; Mende KA; Lago MP; Hany TF
J Nucl Med; 2008 Mar; 49(3):354-61. PubMed ID: 18287263
[TBL] [Abstract][Full Text] [Related]
12. [Detection of a neuroendocrine differentiated cystic pancreatic lesion by gallium-68-DOTATOC-PET/CT with inconclusive MRI, CT and ultrasound diagnosis].
Fröling V; Denecke T; Pöllinger A; Schreiter NF
Rofo; 2010 Feb; 182(2):175-7. PubMed ID: 19998214
[No Abstract] [Full Text] [Related]
13. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
14. Radiology of pancreatic adenocarcinoma: current status of imaging.
Sahani DV; Shah ZK; Catalano OA; Boland GW; Brugge WR
J Gastroenterol Hepatol; 2008 Jan; 23(1):23-33. PubMed ID: 18171340
[TBL] [Abstract][Full Text] [Related]
15. 18F-FDG positron emission tomography CT (FDG PET-CT) in the management of pancreatic cancer: initial experience in 12 patients.
Saif MW; Cornfeld D; Modarresifar H; Ojha B
J Gastrointestin Liver Dis; 2008 Jun; 17(2):173-8. PubMed ID: 18568138
[TBL] [Abstract][Full Text] [Related]
16. Imaging of neuroendocrine tumors.
Tamm EP; Kim EE; Ng CS
Hematol Oncol Clin North Am; 2007 Jun; 21(3):409-32; vii. PubMed ID: 17548032
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic imaging: current and emerging technologies.
Nichols MT; Russ PD; Chen YK
Pancreas; 2006 Oct; 33(3):211-20. PubMed ID: 17003640
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic evaluation of pancreatic cystic malignancies.
Hutchins G; Draganov PV
Surg Clin North Am; 2010 Apr; 90(2):399-410. PubMed ID: 20362794
[TBL] [Abstract][Full Text] [Related]
19. EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma.
Mertz HR; Sechopoulos P; Delbeke D; Leach SD
Gastrointest Endosc; 2000 Sep; 52(3):367-71. PubMed ID: 10968852
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of diagnostic value of cytologic sampling by endoscopic ultrasonography-guided fine-needle aspiration and that by endoscopic retrograde pancreatography for the management of pancreatic mass without biliary stricture.
Wakatsuki T; Irisawa A; Bhutani MS; Hikichi T; Shibukawa G; Takagi T; Yamamoto G; Takahashi Y; Yamada Y; Watanabe K; Obara K; Suzuki T; Sato Y
J Gastroenterol Hepatol; 2005 Nov; 20(11):1707-11. PubMed ID: 16246190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
